Huang HJ

No ORCID on file · 7 papers in corpus
lab-animal 2026
Cell death discovery ·doi:10.1038/s41420-026-03244-2

The aggressive progression and significant chemotherapy resistance of ovarian clear cell carcinoma (OCCC) are closely related to the immunosuppressive tumour microenvironment (TME), but its potential molecular drivers are still unclear. The…

other 2024
BMC cancer ·doi:10.1186/s12885-024-13125-5

BACKGROUND: Ovarian clear cell carcinoma (OCCC) has a disproportionately high incidence among women in East Asia. Patients diagnosed with OCCC tend to experience worse clinical outcomes than those with high-grade serous carcinoma (HGSC) at …

observational 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.1069654

BACKGROUND: No reports on Letrozole as a pretreatment before ablation of uterine fibroid with high intensity focused ultrasound (HIFU), so a retrospective observation study was performed to evaluate the response of different pre-HIFU medica…

case-report 2017
Oncotarget ·doi:10.18632/oncotarget.17708

Benign metastasizing leiomyoma (BML) is a rare disease entity typically presenting as multiple extrauterine leiomyomas associated with a uterine leiomyoma. It has been hypothesized that the extrauterine leiomyomata represent distant metasta…

observational 2017
Advances in clinical and experimental medicine : official organ Wroclaw Medical University ·doi:10.17219/acem/41149

BACKGROUND: Endometriosis (EM) interferes with the reproductive process and affects the success rate of in vitro fertilization (IVF). Inflammatory cytokines are suggested to play a role in infertility in patients with EM. OBJECTIVES: In th…

observational 2015
BMC cancer ·doi:10.1186/s12885-015-1426-3

BACKGROUND: Previous studies assessing second primary malignancies (SPMs) after uterine cancer have been conducted in Western populations with conflicting results. This study aimed to define the incidence and risk of SPMs in Taiwanese patie…

other 1991
Nihon Sanka Fujinka Gakkai zasshi

The expression of aromatase was examined in human endometrium throughout the menstrual cycle, early pregnancy, and ovarian endometriosis with a specific monoclonal antiserum to human purified placental aromatase cytochrome P-450 (P-450AROM)…